Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for blepharophimosis-ptosis-epicanthus inversus syndrome type 2.
2 publications have been identified in PubMed for blepharophimosis-ptosis-epicanthus inversus syndrome type 2. Kisho has analyzed 1 by research type. Research spans Basic Science / Preclinical (100%).
Shen B (2025). [PMID: 40251640](https://pubmed.ncbi.nlm.nih.gov/40251640/). *Human genomics*. [Basic Science / Preclinical]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 2:39 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center